{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T17:43:36Z","timestamp":1760204616666},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,11,29]],"date-time":"2012-11-29T00:00:00Z","timestamp":1354147200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1186\/1471-244x-12-215","type":"journal-article","created":{"date-parts":[[2012,11,30]],"date-time":"2012-11-30T01:15:02Z","timestamp":1354238102000},"source":"Crossref","is-referenced-by-count":15,"title":["Yokukansan (TJ-54) for treatment of pervasive developmental disorder not otherwise specified and Asperger\u2019s disorder: a 12-week prospective, open-label study"],"prefix":"10.1186","volume":"12","author":[{"given":"Tsuyoshi","family":"Miyaoka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rei","family":"Wake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motohide","family":"Furuya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristian","family":"Liaury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masa","family":"Ieda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazunori","family":"Kawakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiko","family":"Tsuchie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuji","family":"Inagaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Horiguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,11,29]]},"reference":[{"key":"1125_CR1","volume-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"2000","unstructured":"American Psychiatric Association: Diagnostic and statistical manual of mental disorders. 2000, Washington D.C. and London, England, Text Revision, 4th","edition":"4th"},{"key":"1125_CR2","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1586\/14737175.2.4.499","volume":"2","author":"KA Stigler","year":"2002","unstructured":"Stigler KA, Posey DJ, MeDougle CJ: Recent advance in the pharmacotherapy of autism. Expert Rev Neurotherapeutics. 2002, 2: 499-510. 10.1586\/14737175.2.4.499.","journal-title":"Expert Rev Neurotherapeutics"},{"key":"1125_CR3","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/9780470939345.ch6","volume-title":"Handbook of autism and pervasive developmental disorders","author":"KE Towbin","year":"2005","unstructured":"Towbin KE: Pervasive developmental disorder not otherwise specified. Handbook of autism and pervasive developmental disorders. Edited by: Volkmar FR, Paul R, Klin A, Cohen D. 2005, New York: John Wiley & Sons, 165-200."},{"key":"1125_CR4","first-page":"417","volume-title":"Understanding autism: from basic neuroscience to treatment","author":"CJ McDougle","year":"2006","unstructured":"McDougle CJ, Posey DJ, Stigler KA: Pharmacological treatments. Understanding autism: from basic neuroscience to treatment. Edited by: Moldin SO, Rubenstein JLR. 2006, Boca Raton: CRC Press, 417-442."},{"issue":"Suppl 10","key":"1125_CR5","first-page":"3","volume":"66","author":"E Fombonne","year":"2005","unstructured":"Fombonne E: Epidemiology of autistic disorder and other pervasive developmental disorders. J Clin Psychiatry. 2005, 66 (Suppl 10): 3-8.","journal-title":"J Clin Psychiatry"},{"key":"1125_CR6","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1203\/PDR.0b013e31819e7203","volume":"65","author":"E Fombonne","year":"2009","unstructured":"Fombonne E: Epidemiological of pervasive developmental disorders. Pediatr Res. 2009, 65: 591-598. 10.1203\/PDR.0b013e31819e7203.","journal-title":"Pediatr Res"},{"key":"1125_CR7","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1089\/cap.2006.16.549","volume":"16","author":"MR Valicenti-McDermott","year":"2006","unstructured":"Valicenti-McDermott MR, Demb H: Clinical effects and adverse reactions of off-label use of aripiprazole in children and adolescents with developmental disabilities. J Child Adolesc Psychopharmacol. 2006, 16: 549-560. 10.1089\/cap.2006.16.549.","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"1125_CR8","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1097\/01.chi.0000220851.94392.30","volume":"45","author":"CU Correll","year":"2006","unstructured":"Correll CU, Carlson HE: Endocrine and metabolic adverse effects of psychotropic medications in children and adolescents. J Am Acad Child Adolesc Psychiatry. 2006, 45: 771-791. 10.1097\/01.chi.0000220851.94392.30.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"1125_CR9","first-page":"565","volume":"25","author":"MG Aman","year":"2005","unstructured":"Aman MG, Arnold LE, McDougle CJ, Vitiello B, Scahill L, Davies M, McCracken JT, Tierney E, Nash PL, Posey DJ, Chuang S, Martin A, Shah B, Gonzalez NM, Swiezy NB, Ritz L, Koenig K, McGough J, Gjuman JK, Lindsay RL: Acute and long-term safety and tolerability of risperidone in children with autism. J Child Adolesc Psychopharmacol. 2005, 25: 565-569.","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"1125_CR10","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.biopsych.2006.02.032","volume":"61","author":"GM Anderson","year":"2007","unstructured":"Anderson GM, Scahill L, McGracken JT, McDougle CJ, Aman MG, Tierney E, Arnold LE, Martin A, Katsovich L, Posey DJ, Shah B, Vitiello B: Effects of short- and long-term risperidone treatment on prolactin levels in children and adolescents with autism. Biol Psychiatry. 2007, 61: 545-550. 10.1016\/j.biopsych.2006.02.032.","journal-title":"Biol Psychiatry"},{"key":"1125_CR11","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1089\/cap.2004.14.593","volume":"14","author":"DH Barzman","year":"2004","unstructured":"Barzman DH, DelBello MP, Kowatch RA, Garnert B, Fleck DE, Pathak S, Rappaport K, Delgado SV, Cmpbell P, Strakowski SM: The effectiveness and tolerability of aripiprazole for pediatric bipolar disorder: A retrospective chart review. J Child Adolesc Psychopharmacol. 2004, 14: 593-600. 10.1089\/cap.2004.14.593.","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"1125_CR12","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.4088\/JCP.v65n1115","volume":"65","author":"AH Corson","year":"2004","unstructured":"Corson AH, Barkenbus JE, Posey DJ, Stigler KA, McDougle CJ: A retrospective analysis of quetiapine in the treatment of pervasive developmental disorders. J Clin Psychiatry. 2004, 65: 1531-1536. 10.4088\/JCP.v65n1115.","journal-title":"J Clin Psychiatry"},{"key":"1125_CR13","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1089\/1044546041649129","volume":"14","author":"RL Finding","year":"2004","unstructured":"Finding RL, McNamara N, Gracious BL, O\u2019Riordan MA, Reed MD, Demeter C, Blumer JL: Quetiapine in nine youths with autistic disorder. J Child Adolesc Psychopharmacol. 2004, 14: 287-294. 10.1089\/1044546041649129.","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"1125_CR14","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s10803-005-3306-1","volume":"35","author":"AY Hardan","year":"2005","unstructured":"Hardan AY, Jou RJ, Handen BL: Retrospective study of quetiapine in children and adolescents with pervasive developmental disorders. J Autism Dev Disord. 2005, 35: 387-391. 10.1007\/s10803-005-3306-1.","journal-title":"J Autism Dev Disord"},{"key":"1125_CR15","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1089\/cap.2004.14.455","volume":"14","author":"KA Stigler","year":"2004","unstructured":"Stigler KA, Posey DJ, McDougle CJ: Aripiprazole for maladaptive behavior in pervasive developmental disorders. J Child Adolesc Psychopharmacol. 2004, 14: 455-463. 10.1089\/cap.2004.14.455.","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"1125_CR16","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s11940-010-0091-8","volume":"12","author":"K Logan","year":"2010","unstructured":"Logan K, Wink MD, Craig A, Erickson MD, Christopher J, McDougle MD: Pharmacologic treatment of behavioral symptoms associated with autism and other pervasive developmental disorders. Curr Treat Options Neurol. 2010, 12: 529-538. 10.1007\/s11940-010-0091-8.","journal-title":"Curr Treat Options Neurol"},{"key":"1125_CR17","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1046\/j.1440-1819.2002.01006.x","volume":"56","author":"R Aizawa","year":"2002","unstructured":"Aizawa R, Kanbayashi T, Saito Y: Effects of yoku-kan-san-ka-chipi-hange on the sleep of normal healthy adult subjects. Psychiatry Clin Neurosci. 2002, 56: 303-304. 10.1046\/j.1440-1819.2002.01006.x.","journal-title":"Psychiatry Clin Neurosci"},{"key":"1125_CR18","first-page":"12","volume":"16","author":"K Iwasaki","year":"2005","unstructured":"Iwasaki K, Maruyama M, Tomita N, Furukawa K, Nemoto M, Fujiwara H, Seki T, Fujii M, Kodama M, Arai H: Effects of traditional Chinese herbal medicine Yi-gan san for cholinesterase inhibitor-resistant visual hallucinations and neuropsychiatric symptoms in patients with dementia with Lewy bodies. J Clin Psychiatry. 2005, 16: 12-13.","journal-title":"J Clin Psychiatry"},{"key":"1125_CR19","first-page":"105","volume":"1","author":"E Tahara","year":"2003","unstructured":"Tahara E, Shimizu T, Moriyama K: Two cases with positive symptoms by dementia of elderly successfully treated with yokukan-san (in Japanese, abstract in English). Kampo-no-Rinsho;. 2003, 1: 105-114.","journal-title":"Kampo-no-Rinsho;"},{"key":"1125_CR20","doi-asserted-by":"publisher","first-page":"248","DOI":"10.4088\/JCP.v66n0214","volume":"66","author":"K Iwasaki","year":"2005","unstructured":"Iwasaki K, Satoh-Nakagawa T, Maruyama M: A randomized observer-blind, controlled trial of the traditional Chinese medicine Yi-Gan San for improvement of behavioral and psychological symptoms and activities of daily living in dementia patients. J Clin Psychiatry. 2005, 66: 248-252. 10.4088\/JCP.v66n0214.","journal-title":"J Clin Psychiatry"},{"key":"1125_CR21","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.pnpbp.2007.07.026","volume":"32","author":"T Miyaoka","year":"2008","unstructured":"Miyaoka T, Furuya M, Yasuda H, Hayashida M, Inagaki T, Hoiriguchi J: Ti-gan san for treatment of borderline personality disorder: an open-label study. Prog Neuropsychopharm & Biol Psychiatry. 2008, 32: 150-154. 10.1016\/j.pnpbp.2007.07.026.","journal-title":"Prog Neuropsychopharm & Biol Psychiatry"},{"key":"1125_CR22","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.pnpbp.2007.12.003","volume":"32","author":"T Miyaoka","year":"2008","unstructured":"Miyaoka T, Furuya M, Yasuda H, Hayashida M, Ingaki T, Horiguchi J: Yi-gansan for treatment of neuroleptic-induced tardive dyskinesia: an open-label study. Prog Neuropsychopharm & Biol Psychiatry. 2008, 32: 761-764. 10.1016\/j.pnpbp.2007.12.003.","journal-title":"Prog Neuropsychopharm & Biol Psychiatry"},{"key":"1125_CR23","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.pnpbp.2008.12.005","volume":"33","author":"T Miyaoka","year":"2009","unstructured":"Miyaoka T, Furuya M, Yasuda H, Hayashida M, Inagaki T, Horiguchi J: Charles Bonnet syndrome: successful treatment of visual hallucinations due to vision loss with Yi-gan san. Prog Neuropsychopharmacol Biol Psychiatry. 2009, 33: 382-383. 10.1016\/j.pnpbp.2008.12.005.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"1125_CR24","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1097\/WNF.0b013e31817e08c3","volume":"32","author":"T Miyaoka","year":"2009","unstructured":"Miyaoka T, Furuya M, Yasuda H, Hayashida M, Nishida A, Insagaki T, Horiguchi J: Yi-gan san as adjunctive therapy for treatment-resistant schizophrenia: an open-label study. Clin Neuopharmacol. 2009, 32: 6-9. 10.1097\/WNF.0b013e31817e08c3.","journal-title":"Clin Neuopharmacol"},{"key":"1125_CR25","doi-asserted-by":"publisher","first-page":"271","DOI":"10.2174\/157340009789542114","volume":"5","author":"T Miyaoka","year":"2009","unstructured":"Miyaoka T, Horiguchi J: Clinical potential of Yi-gan san (Yokukansan) for psychiatric disorders. Curr Psychiatry Rev. 2009, 5: 271-275. 10.2174\/157340009789542114.","journal-title":"Curr Psychiatry Rev"},{"key":"1125_CR26","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1097\/WNF.0b013e318206785a","volume":"34","author":"T Miyaoka","year":"2011","unstructured":"Miyaoka T, Furuya M, Kristian L, Wake R, Kawakami K, Nagahama M, Kawano K, Ieda M, Tsuchie K, Horiguchi J: Yi-gan san for treatment of Charles Bonnet syndrome (visual hallucination due to vision loss): An open-label study. Clin Neuropharmacol. 2011, 34: 24-27. 10.1097\/WNF.0b013e318206785a.","journal-title":"Clin Neuropharmacol"},{"key":"1125_CR27","first-page":"1995","volume-title":"Structured clinical interview for DSM-IV axis I disorders","author":"MB First","year":"1995","unstructured":"First MB, Rl S, Gibbon M, Williams JBW: Structured clinical interview for DSM-IV axis I disorders. 1995, New York: American Psychiatric Press, 1995-"},{"key":"1125_CR28","volume-title":"Structured clinical interview for DSM-IV axis II personality disorders (SCID-II)","author":"MB First","year":"1997","unstructured":"First MB: Structured clinical interview for DSM-IV axis II personality disorders (SCID-II). 1997, Washington, DC: American Pyschiatric Publishing"},{"key":"1125_CR29","volume-title":"Wechsler intelligence scale for children","author":"D Wechsler","year":"1999","unstructured":"Wechsler D: Wechsler intelligence scale for children. 1999, San Antonio (Texas): Psychological Corporation, 3rd","edition":"3rd"},{"key":"1125_CR30","first-page":"218","volume-title":"ECDEU assessment manual for psychopharmacogy-revised","author":"W Guy","year":"1976","unstructured":"Guy W: ECDEU assessment manual for psychopharmacogy-revised. 1976, Rockville, MD, U.S.: Department of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, NIMH Psychopharmacology Research Branch, Division of Extramural Research Programs, 218-222."},{"key":"1125_CR31","first-page":"485","volume":"89","author":"MG Aman","year":"1985","unstructured":"Aman MG, Singh NN, Stewart AW, Field CJ: The aberrant behavior checklist: a behavior rating scale for the assessment of treatment effects. Am J Ment Defic. 1985, 89: 485-491.","journal-title":"Am J Ment Defic"},{"key":"1125_CR32","volume-title":"Supplement to aberrant behavior checklist manual","author":"MG Aman","year":"1994","unstructured":"Aman MG, Singh NN: Supplement to aberrant behavior checklist manual. 1994, East Aurora (New York): Slosson Educational Publications"},{"key":"1125_CR33","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1056\/NEJMoa013171","volume":"347","author":"Research Units on Pediatric Psychopharmacology (RUPP) Autism Network","year":"2002","unstructured":"Research Units on Pediatric Psychopharmacology (RUPP) Autism Network: Risperidone in children with autism and serious behavioral problems. N Engl J Med. 2002, 347: 314-321. 10.1056\/NEJMoa013171.","journal-title":"N Engl J Med"},{"key":"1125_CR34","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1176\/appi.ajp.162.7.1361","volume":"162","author":"Research Units on Pediatric Psychopharmacology (RUPP) Autism Network","year":"2005","unstructured":"Research Units on Pediatric Psychopharmacology (RUPP) Autism Network: Risperidone treatment of autistic disorder: longer term benefits and blinded discontinuation after 6 months. Am J Psychiatry. 2005, 162: 1361-1369.","journal-title":"Am J Psychiatry"},{"key":"1125_CR35","doi-asserted-by":"publisher","first-page":"e634","DOI":"10.1542\/peds.2003-0264-F","volume":"114","author":"S Shea","year":"2004","unstructured":"Shea S, Turgay A, Carroll A, Schulz M, Orlik H, Smith I, Dunbar F: Risperidone treatment of disruptive behavioral symptoms in children with austic and other pervasive developmental disorders. Pediatrics. 2004, 114: e634-641. 10.1542\/peds.2003-0264-F.","journal-title":"Pediatrics"},{"key":"1125_CR36","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S0891-4222(01)00091-9","volume":"23","author":"EC Brown","year":"2002","unstructured":"Brown EC, Aman MG, Harecamp SM: Factor analysis and norms on parent rating with the aberrant behavior checklist: community for young people in social education. Res Dev Disabil. 2002, 23: 45-60. 10.1016\/S0891-4222(01)00091-9.","journal-title":"Res Dev Disabil"},{"key":"1125_CR37","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1097\/00005053-197611000-00003","volume":"163","author":"JJ Bartko","year":"1976","unstructured":"Bartko JJ, Carpenter WT: On the methods and theory of reliability. J Nerv Ment Dis. 1976, 163: 307-317. 10.1097\/00005053-197611000-00003.","journal-title":"J Nerv Ment Dis"},{"key":"1125_CR38","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1097\/01.chi.0000142668.29191.13","volume":"43","author":"LL Greenhill","year":"2009","unstructured":"Greenhill LL, Vitiello B, Fisher P, Levien J, Davies M, Abikoff H, Crisman AK, Chauan S, Finding RL, March J, Scahill L, Walkup J, Riddle MA: Comparison of increasingly detailed elicitation methods for the assessment of adverse events in periatric psychopharmacology. J Am Acad Child Adlesc Psychiatry. 2009, 43: 1488-1496.","journal-title":"J Am Acad Child Adlesc Psychiatry"},{"key":"1125_CR39","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1211\/jpp\/61.09.0016","volume":"61","author":"H Kanno","year":"2009","unstructured":"Kanno H, Sekiguchi K, Yamaguchi T, Terawaki K, Yuzurihara M, Kase Y, Ikarashi Y: Effect of yokukansan, a traditional Japanese medicine, on social and aggressive behavior of para-chloro amphetamine-injected rat. J Pharm Pharmacol. 2009, 61: 1249-1256.","journal-title":"J Pharm Pharmacol"},{"key":"1125_CR40","first-page":"151","volume":"19","author":"JF Liao","year":"1995","unstructured":"Liao JF, Jan YM, Huang SY: Evaluation with receptor binding assay on the water extracts of ten CNS-active Chinese herbal drugs. Proc Natl Sci Counc Repub China B. 1995, 19: 151-158.","journal-title":"Proc Natl Sci Counc Repub China B"},{"key":"1125_CR41","first-page":"176","volume-title":"Ameliorative effect of yokukansan an aggressive behavior in social isolated mice","author":"A Nishi","year":"2010","unstructured":"Nishi A, Yamaguchi T, Sekiguchi K, Ikarashi Y, Kase Y: Ameliorative effect of yokukansan an aggressive behavior in social isolated mice. 2010, London, England: The 40th Annual Meeting of Japanese Society of Neuropsychopharmacology, 176-Abstract"},{"key":"1125_CR42","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1211\/0022357991772853","volume":"51","author":"Y Shimada","year":"1999","unstructured":"Shimada Y, Goto H, Itoh T: Evaluation of the protective effects of alkaloids isolated from the hooks and stems of uncaria sinesis on glutamate-induced neuronal death in cultured cerebellar granule cells from rats. J Pharm Pharmcol. 1999, 51: 715-722. 10.1211\/0022357991772853.","journal-title":"J Pharm Pharmcol"},{"issue":"Suppl","key":"1125_CR43","first-page":"9","volume":"66","author":"CJ McDougle","year":"2005","unstructured":"McDougle CJ, Erickson CA, Stigler KA, Posey DJ: Neurochemistry in the pathophysiology of autism. J Clin Psychiatry. 2005, 66 (Suppl): 9-18.","journal-title":"J Clin Psychiatry"},{"key":"1125_CR44","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1017\/S0954579402003103","volume":"14","author":"G Dawson","year":"2002","unstructured":"Dawson G, Webb S, Shellenberg GD, Dager S, Friedman S, Aylward E, Richards T: Defining the broader phenotype of autism: genetic, brain, and behavioral perspectives. Dev Psychopathol. 2002, 14: 581-611.","journal-title":"Dev Psychopathol"},{"key":"1125_CR45","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1093\/ije\/dyh299","volume":"34","author":"AG Barnett","year":"2005","unstructured":"Barnett AG, van der Pols JC, Dobson AJ: Regression to the mean: what it is and how to deal with it. Int J Epidemiol. 2005, 34: 215-220.","journal-title":"Int J Epidemiol"},{"key":"1125_CR46","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/BF02172145","volume":"24","author":"C Lord","year":"1994","unstructured":"Lord C, Ruter M, Le Couteur AM: Autism diagnostic interview revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. J Autism Dev. 1994, 24: 659-685. 10.1007\/BF02172145.","journal-title":"J Autism Dev"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-244X-12-215.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-244X-12-215\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-244X-12-215","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T18:25:01Z","timestamp":1643739901000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/1471-244X-12-215"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11,29]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["1125"],"URL":"https:\/\/doi.org\/10.1186\/1471-244x-12-215","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11,29]]},"article-number":"215"}}